Date,Title,Source
2025-09-06T06:16:56Z,Biotech Stocks To Consider – September 4th,ETF Daily News
2025-09-05T09:41:12Z,Biotech Stocks To Consider – September 2nd,ETF Daily News
2025-09-05T05:42:51Z,Top Biotech Stocks Worth Watching – September 3rd,ETF Daily News
2025-09-04T08:32:58Z,Promising Biotech Stocks To Add to Your Watchlist – September 1st,ETF Daily News
2025-09-03T21:00:05Z,Here's How Much You Would Have Made Owning AbbVie Stock In The Last 5 Years,Biztoc.com
2025-09-03T17:41:21Z,AbbVie (ABBV) Advances Cancer Treatments With Epcoritamab And Mirvetuximab Approvals,Yahoo Entertainment
2025-09-03T07:02:52Z,Biotech Stocks To Research – August 31st,ETF Daily News
"Sat, 06 Sep 2025 17:17:05 GMT",AbbVie (ABBV) Declares US$1.64 Quarterly Dividend for Shareholders - Yahoo Finance,Yahoo Finance
"Mon, 08 Sep 2025 02:16:15 GMT",1 Reason Every Investor Should Know About AbbVie (ABBV) - Mitrade,Mitrade
"Sun, 07 Sep 2025 21:27:16 GMT",AbbVie’s ABBV-932 Study: A Closer Look at Bioavailability and Market Impact - MSN,MSN
"Wed, 03 Sep 2025 12:30:00 GMT",AbbVie Announces Updated Results From Phase 2 EPCORE® NHL-6 Study Evaluating the Potential for Outpatient Monitoring of Epcoritamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) - PR Newswire,PR Newswire
"Wed, 03 Sep 2025 17:48:45 GMT",AbbVie (ABBV) Advances Cancer Treatments With Epcoritamab And Mirvetuximab Approvals - simplywall.st,simplywall.st
"Fri, 05 Sep 2025 13:09:32 GMT",AbbVie (ABBV) Declares $1.64 Quarterly Dividend; 3.1% Yield - StreetInsider,StreetInsider
"Thu, 04 Sep 2025 19:40:26 GMT",AbbVie Inc. (NYSE:ABBV) Is a Favorite Amongst Institutional Investors Who Own 74% - 富途牛牛,富途牛牛
"Sat, 06 Sep 2025 07:41:15 GMT",What is the PEG ratio of ABBV - July 2025 Momentum & Fast Moving Market Watchlists - 강소기업뉴스,강소기업뉴스
"Sun, 07 Sep 2025 17:17:29 GMT",AbbVie’s New Phase 1 Study: A Closer Look at ABBV-8736 - TipRanks,TipRanks
"Sat, 06 Sep 2025 09:25:39 GMT",ABBV Shows Risk Reward Favoring Upside - Market Trend Review & Weekly Consistent Profit Watchlists - beatles.ru,beatles.ru
"Sun, 07 Sep 2025 17:09:49 GMT",AbbVie’s ABBV-277 Study: A New Frontier in Drug Safety Evaluation - TipRanks,TipRanks
"Sun, 07 Sep 2025 21:50:34 GMT",Is ABBV backed by strong institutional buying - Weekly Trade Report & Daily Profit Focused Screening - 강소기업뉴스,강소기업뉴스
"Sun, 07 Sep 2025 17:09:16 GMT",AbbVie’s ABBV-525 Study: A Potential Game-Changer in B-Cell Malignancies - TipRanks,TipRanks
"Sun, 07 Sep 2025 16:54:17 GMT",AbbVie’s ABBV-383 Study: A New Hope for Multiple Myeloma Treatment? - TipRanks,TipRanks
"Sun, 07 Sep 2025 16:47:23 GMT",AbbVie’s Promising Phase 1 Study on ABBV-706 in Advanced Solid Tumors - TipRanks,TipRanks
"Sun, 07 Sep 2025 17:47:32 GMT",AbbVie’s Promising Phase 2 Study on ABBV-932 for Anxiety Disorder - TipRanks,TipRanks
"Sun, 07 Sep 2025 17:11:34 GMT",AbbVie’s Promising Study on ABBV-706 for Small Cell Lung Cancer - TipRanks,TipRanks
"Thu, 04 Sep 2025 17:48:45 GMT",AbbVie’s ABBV-400 Study: A New Hope for Advanced Solid Tumors - TipRanks,TipRanks
"Fri, 05 Sep 2025 18:26:02 GMT",Is ABBV backed by strong institutional buying - July 2025 Big Picture & Safe Capital Allocation Plans - خودرو بانک,خودرو بانک
"Sat, 06 Sep 2025 09:02:38 GMT",What is ABBV’s book value per share - July 2025 Trade Ideas & Step-by-Step Swing Trade Plans - خودرو بانک,خودرو بانک
"Fri, 05 Sep 2025 01:54:51 GMT",What is ABBV’s book value per share - Weekly Trade Summary & Stock Timing and Entry Methods - خودرو بانک,خودرو بانک
"Wed, 03 Sep 2025 15:49:11 GMT",Insider Trends: Will ABBV face regulatory challenges - 2025 Performance Recap & Low Risk Growth Stock Ideas - خودرو بانک,خودرو بانک
"Wed, 03 Sep 2025 07:00:00 GMT",Does ABBV have a sustainable dividend - 2025 Performance Recap & Community Trade Idea Sharing Platform - خودرو بانک,خودرو بانک
"Thu, 04 Sep 2025 13:17:00 GMT",Will AbbVie's Neuroscience Portfolio Continue to Aid Top-line Growth? - TradingView,TradingView
"Thu, 04 Sep 2025 00:58:21 GMT",AbbVie’s $0.84 Billion Volume Tumbles to 100th as Regulatory Uncertainty and Biosimilar Delays Weigh on Investor Sentiment - AInvest,AInvest
"Wed, 03 Sep 2025 14:22:14 GMT",AbbVie updates mid-stage trial data for Genmab-partnered lymphoma drug in outpatient setting - Seeking Alpha,Seeking Alpha
"Mon, 08 Sep 2025 04:15:46 GMT",Tick level data insight on ABBV volatility - Portfolio Gains Report & Daily Stock Trend Reports - Newser,Newser
"Mon, 08 Sep 2025 05:39:44 GMT",Does ABBV show high probability of rebound - Wall Street Watch & Low Risk High Reward Ideas - Newser,Newser
"Sun, 07 Sep 2025 22:51:35 GMT",Using AI based signals to follow ABBV - July 2025 Closing Moves & Smart Swing Trading Alerts - Newser,Newser
"Mon, 08 Sep 2025 05:24:42 GMT",Using economic indicators to assess ABBV potential - July 2025 Review & Weekly Breakout Watchlists - Newser,Newser
"Sat, 06 Sep 2025 07:27:20 GMT",AbbVie Inc. ABBV Posts 0.21% Drop Amid Short-Term Challenges and Strategic Shifts - AInvest,AInvest
"Sun, 07 Sep 2025 05:02:06 GMT",Assessing AbbVie’s Dividend Sustainability Amid Evolving Market Dynamics - AInvest,AInvest
"Sat, 06 Sep 2025 23:50:02 GMT",Why AbbVie's Dividend Resilience Signals Strong Long-Term Investment Potential - AInvest,AInvest
"Sat, 06 Sep 2025 17:53:51 GMT",AbbVie’s Dividend Sustainability and Valuation: Does the High Yield Justify the Price? - AInvest,AInvest
"Sat, 06 Sep 2025 07:28:00 GMT",Stock Analysis | Abbvie Outlook - Technical Strength and Optimism Amid Strong Analyst Backing - AInvest,AInvest
"Sun, 07 Sep 2025 04:12:03 GMT",Assessing AbbVie's Dividend Sustainability Amidst Earnings Volatility - AInvest,AInvest
"Fri, 05 Sep 2025 00:54:06 GMT","AbbVie Shares Rise 0.54% on Epcoritamab Trial Progress, Daily Volume Ranks 119th - AInvest",AInvest
"Sun, 07 Sep 2025 00:41:56 GMT",AbbVie's Dividend Resilience and Growth Prospects in a Shifting Market - AInvest,AInvest
"Sun, 07 Sep 2025 18:43:23 GMT","Triple Threat: AbbVie, Enbridge, and ExxonMobil Lead the Way in Dividend Investing - AInvest",AInvest
"Sat, 06 Sep 2025 01:07:04 GMT",AbbVie's $950M Volume Drives 90th Market Rank Amid 310% Dividend Surge and Therapeutic Expansion - AInvest,AInvest
"Fri, 05 Sep 2025 15:04:02 GMT",AbbVie Inc. Announces Quarterly Dividend of $1.64 per Share - AInvest,AInvest
"Thu, 04 Sep 2025 07:41:31 GMT",Stock Analysis | Abbvie Outlook - A Mixed Bag Amid Fundamental Strength and Market Neutrality - AInvest,AInvest
"Fri, 05 Sep 2025 07:26:32 GMT",Stock Analysis | Abbvie Outlook - Technical Neutrality and Strong Fundamentals Amid Mixed Analyst Ratings - AInvest,AInvest
2025-09-05T16:07:00,AbbVie Declares Quarterly Dividend,Yahoo
2025-09-04T16:17:00,Will AbbVie's Neuroscience Portfolio Continue to Aid Top-line Growth?,Yahoo
2025-09-04T13:41:02,AbbVie and Genmab’s Epkinly shows outpatient viability in Phase II trial,Yahoo
2025-09-04T12:46:00,Anti-Parkinson's Drugs Global Market Research Report 2025-2030 | $9.2 Bn Opportunities Driven by Increased Awareness in Emerging Countries and a Robust Pipeline of Innovations,Yahoo
2025-09-04T12:05:13,Health Canada approves AbbVie’s Elahere for ovarian cancer,Yahoo
2025-09-03T20:41:21,AbbVie (ABBV) Advances Cancer Treatments With Epcoritamab And Mirvetuximab Approvals,Yahoo
2025-09-03T15:30:00,AbbVie Announces Updated Results From Phase 2 EPCORE® NHL-6 Study Evaluating the Potential for Outpatient Monitoring of Epcoritamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL),Yahoo
2025-09-03T15:00:00,Allergan Aesthetics Launches Campaign to Educate Consumers about Hyaluronic Acid (HA) Injectable Fillers,Yahoo
